Serveur d'exploration sur la rapamycine et les champignons - Exploration (Accueil)

Index « KwdFr.i » - entrée « Phosphatidylinositol 3-kinases (composition chimique) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Phosphatidylinositol 3-kinases (classification) < Phosphatidylinositol 3-kinases (composition chimique) < Phosphatidylinositol 3-kinases (déficit)  Facettes :

List of bibliographic references indexed by Phosphatidylinositol 3-kinases (composition chimique)

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000469 (2018) Maristella De Cicco [Allemagne] ; Lech-G Milroy [Pays-Bas] ; Sonja A. Dames [Allemagne]Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study.
000509 (2018) Andrew Hill [États-Unis] ; Brad Niles [États-Unis] ; Andrew Cuyegkeng [États-Unis] ; Ted Powers [États-Unis]Redesigning TOR Kinase to Explore the Structural Basis for TORC1 and TORC2 Assembly.
000539 (2018) Gabriel Castro-Falc N [États-Unis] ; Grant S. Seiler [États-Unis] ; Özlem Demir [États-Unis] ; Manoj K. Rathinaswamy [Canada] ; David Hamelin [Canada] ; Reece M. Hoffmann [Canada] ; Stefanie L. Makowski [États-Unis] ; Anne-Catrin Letzel [États-Unis] ; Seth J. Field [États-Unis] ; John E. Burke [Canada] ; Rommie E. Amaro [États-Unis] ; Chambers C. Hughes [États-Unis]Neolymphostin A Is a Covalent Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitor That Employs an Unusual Electrophilic Vinylogous Ester.
000619 (2018) Denise Rageot [Suisse] ; Thomas Bohnacker [Suisse] ; Anna Melone [Suisse] ; Jean-Baptiste Langlois [Suisse] ; Chiara Borsari [Suisse] ; Petra Hillmann [Suisse] ; Alexander M. Sele [Suisse] ; Florent Beaufils [Suisse] ; Marketa Zvelebil [Suisse] ; Paul Hebeisen [Suisse] ; Wolfgang Löscher [Allemagne] ; John Burke [Canada] ; Doriano Fabbro [Suisse] ; Matthias P. Wymann [Suisse]Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders.
000629 (2018) Iva Lu I [Autriche] ; Manoj K. Rathinaswamy [Canada] ; Linda Truebestein [Autriche] ; David J. Hamelin [Canada] ; John E. Burke [Canada] ; Thomas A. Leonard [Autriche]Conformational sampling of membranes by Akt controls its activation and inactivation.
000C63 (2015) Christl Gaubitz [Suisse] ; Taiana M. Oliveira [France] ; Manoel Prouteau [Suisse] ; Alexander Leitner [Suisse] ; Manikandan Karuppasamy [France] ; Georgia Konstantinidou [Suisse] ; Delphine Rispal [Suisse] ; Sandra Eltschinger [Suisse] ; Graham C. Robinson [Suisse] ; Stéphane Thore [France] ; Ruedi Aebersold [Suisse] ; Christiane Schaffitzel [Royaume-Uni] ; Robbie Loewith [Suisse]Molecular Basis of the Rapamycin Insensitivity of Target Of Rapamycin Complex 2.
000E97 (2014) Carrie L. Lucas [États-Unis] ; Hye Sun Kuehn [États-Unis] ; Fang Zhao [États-Unis] ; Julie E. Niemela [États-Unis] ; Elissa K. Deenick [Australie] ; Umaimainthan Palendira [Australie] ; Danielle T. Avery [Australie] ; Leen Moens [Australie] ; Jennifer L. Cannons [États-Unis] ; Matthew Biancalana [États-Unis] ; Jennifer Stoddard [États-Unis] ; Weiming Ouyang [États-Unis] ; David M. Frucht [États-Unis] ; V Koneti Rao [États-Unis] ; T Prescott Atkinson [États-Unis] ; Anahita Agharahimi [États-Unis] ; Ashleigh A. Hussey [États-Unis] ; Les R. Folio [États-Unis] ; Kenneth N. Olivier [États-Unis] ; Thomas A. Fleisher [États-Unis] ; Stefania Pittaluga [États-Unis] ; Steven M. Holland [États-Unis] ; Jeffrey I. Cohen [États-Unis] ; Joao B. Oliveira [Brésil] ; Stuart G. Tangye [Australie] ; Pamela L. Schwartzberg [États-Unis] ; Michael J. Lenardo [États-Unis] ; Gulbu Uzel [États-Unis]Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.
000F08 (2014) Lisa A M. Sommer [Allemagne] ; J Joel Janke ; W F Drew Bennett ; Jochen Bürck ; Anne S. Ulrich ; D Peter Tieleman ; Sonja A. DamesCharacterization of the immersion properties of the peripheral membrane anchor of the FATC domain of the kinase "target of rapamycin" by NMR, oriented CD spectroscopy, and MD simulations.
000F10 (2014) Lisa A M. Sommer [Allemagne] ; Sonja A. Dames [Allemagne]Characterization of residue-dependent differences in the peripheral membrane association of the FATC domain of the kinase 'target of rapamycin' by NMR and CD spectroscopy.
001244 (2011) Nobuyasu Ikai [Japon] ; Norihiko Nakazawa ; Takeshi Hayashi ; Mitsuhiro YanagidaThe reverse, but coordinated, roles of Tor2 (TORC1) and Tor1 (TORC2) kinases for growth, cell cycle and separase-mediated mitosis in Schizosaccharomyces pombe.
001329 (2011) Rui Gong [République populaire de Chine] ; Li Li ; Yi Liu ; Ping Wang ; Huirong Yang ; Ling Wang ; Jingdong Cheng ; Kun-Liang Guan ; Yanhui XuCrystal structure of the Gtr1p-Gtr2p complex reveals new insights into the amino acid-induced TORC1 activation.
001548 (2009) Thomas W. Sturgill [États-Unis] ; Michael N. HallActivating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha.
001581 (2008) Thomas W. Sturgill [États-Unis] ; Adiel Cohen ; Melanie Diefenbacher ; Mark Trautwein ; Dietmar E. Martin ; Michael N. HallTOR1 and TOR2 have distinct locations in live cells.
001681 (2007) Alessandra Adami [Royaume-Uni] ; Bego A García-Alvarez ; Ernesto Arias-Palomo ; David Barford ; Oscar LlorcaStructure of TOR and its complex with KOG1.
001699 (2007) Takeshi Hayashi [Japon] ; Mitsuko Hatanaka ; Koji Nagao ; Yukinobu Nakaseko ; Junko Kanoh ; Aya Kokubu ; Masahiro Ebe ; Mitsuhiro YanagidaRapamycin sensitivity of the Schizosaccharomyces pombe tor2 mutant and organization of two highly phosphorylated TOR complexes by specific and common subunits.
001797 (2006) Aaron Reinke [États-Unis] ; Jenny C-Y Chen ; Sofia Aronova ; Ted PowersCaffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p.
001808 (2005) Sonja A. Dames [Suisse] ; José M. Mulet ; Klara Rathgeb-Szabo ; Michael N. Hall ; Stephan GrzesiekThe solution structure of the FATC domain of the protein kinase target of rapamycin suggests a role for redox-dependent structural and cellular stability.
001833 (2005) Stephan Wullschleger [Suisse] ; Robbie Loewith ; Wolfgang Oppliger ; Michael N. HallMolecular organization of target of rapamycin complex 2.
001872 (2004) Aaron Reinke [États-Unis] ; Scott Anderson ; J Michael Mccaffery ; John Yates ; Sofia Aronova ; Stephanie Chu ; Stephen Fairclough ; Cory Iverson ; Karen P. Wedaman ; Ted PowersTOR complex 1 includes a novel component, Tco89p (YPL180w), and cooperates with Ssd1p to maintain cellular integrity in Saccharomyces cerevisiae.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Phosphatidylinositol 3-kinases (composition chimique)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Phosphatidylinositol 3-kinases (composition chimique)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Phosphatidylinositol 3-kinases (composition chimique)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020